Eun‐Ji Choi
ORCID: 0000-0002-9568-8877
· 1 paper in corpus
Abstract Background Improvement of cytopenia is one of the primary treatment purposes for patients with the lower-risk myelodysplastic syndrome (MDS). Androgens have been used for the treatment of aplastic anemia, immune thrombocytopenia, a…